73354-15-1

Basic information

• Product Name: 9-O-Acetyl-4,4'-di-O-methyllariciresil
• Synonyms: 9-O-Acetyl-4,4'-di-O-methyllariciresil;9-O-Acetyl-4,4'-di-O-Methyllariciresinol
• CAS NO: 73354-15-1
• Molecular Formula: C24H30O7
• Molecular Weight: 430.5
• Mol File: 73354-15-1.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 534.4±50.0 °C(Predicted)
• Appearance: /
• Density: 1.145±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 9-O-Acetyl-4,4'-di-O-methyllariciresil(CAS DataBase Reference)
• NIST Chemistry Reference: 9-O-Acetyl-4,4'-di-O-methyllariciresil(73354-15-1)
• EPA Substance Registry System: 9-O-Acetyl-4,4'-di-O-methyllariciresil(73354-15-1)

Safety Data

• Hazardous Substances Data: 73354-15-1(Hazardous Substances Data)

Usage

General Description

9-O-Acetyl-4,4'-di-O-methyllariciresinol is a chemical compound known for its potential antioxidant and anti-inflammatory properties. It is a lignan, a type of phytochemical found in certain plants, and is primarily found in flaxseeds and some fruits and vegetables. Research suggests that this compound may have health benefits such as lowering cholesterol levels and reducing the risk of cardiovascular disease. Additionally, it has been investigated for its potential anticancer effects. Overall, 9-O-Acetyl-4,4'-di-O-methyllariciresinol shows promise as a natural compound with various potential health benefits and is the subject of ongoing research.

Upstream product

• 95810-25-6 (4-(3,4-dimethoxybenzyl)-2-(3,4-dimethoxyphenyl)tetrahydrofuran-3-yl)methanol 
• 108-24-7 acetic anhydride 
• 40918-90-9 3'-Hydroxymethyleugenol 

Relevant articles and documents

Site- And enantiodifferentiating C(sp3)-H oxidation enables asymmetric access to structurally and stereochemically diverse saturated cyclic ethers

A manganese-catalyzed site- and enantiodifferentiating oxidation of C(sp3)-H bonds in saturated cyclic ethers has been described. The mild and practical method is applicable to a range of tetrahydrofurans, tetrahydropyrans, and medium-sized cyclic ethers with multiple stereocenters and diverse substituent patterns in high efficiency with extremely efficient site- and enantiodiscrimination. Late-stage application in complex biological active molecules was further demonstrated. Mechanistic studies by combined experiments and computations elucidated the reaction mechanism and origins of stereoselectivity. The ability to employ ether substrates as the limiting reagent, together with a broad substrate scope, and a high level of chiral recognition, represent a valuable demonstration of the utility of asymmetric C(sp3)-H oxidation in complex molecule synthesis.